European Stocks to Watch: Novartis

Swiss drug maker Novartis was the only gainer on Zurich's SMI index Wednesday, rising 0.2%, after an American federal court extended a temporary restraining order blocking a generic version of the pharmaceutical's high-blood-pressure drug Lotrel.

Copies of the Novartis drug, made by Israel-based Teva Pharmaceutical were halted, apart from shipments already on the way to customers.

The move is a boost for the major pharmaceutical companies, which have come under increasing pressure from generic competition in recent years.

Eurotunnel (Up 56%) Shares in the cross-channel train operator continued to soar for a second day following positive reaction to its public share swap offer Tuesday, which effectively re-floated the company with newly issued shares after a week-long suspension.

Air Berlin (Down 5.3%) Ulf Huettmeyer, finance chief of the German carrier, said he is expecting an earnings before interest and tax (EBIT) margin of about 6% for the full year, which is at the low end of its previous target of 6-7%, when speaking on a conference call.

LogicaCMG (Up 3.9%) Following the announcement that Chief Executive Martin Read is to step down from the London listed IT company, speculation is mounting about a possible takeover from private equity firm Permira.

EADS (Down 1.3%) Shares in the owner of Airbus declined as the plane maker said it was to boost jobs outsourcing to 50%, from a current 20-25%, the managing director of its U.K. unit told Reuters.

Contact U.S. News


    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

Don't Miss

U.S. Video

  • Gene Munster, Piper Jaffray analyst, discusses Apple hitting an all-time high and says his price target is $135. He also discusses Amazon's surprise profit, and Google's big miss, as well.

  • Adam Parker, chief U.S. equity strategist, Morgan Stanley, discusses earning so far, and says they're about what he expected. He sees 6 percent earnings as a base case for the year.

  • CNBC's Jim Cramer explains why he is watching shares of Costco.